Search Within

Sergio Andres Giralt

  1. "Valkal Bhatt"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (7)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (47)
  2. Center for Hematologic Malignancies (47)
  3. Department of Medicine (47)
  4. Hematologic Malignancies, Division of (47)
  5. CTCR Scholars (42)
  6. Survivorship Research (38)

More Groups

People
  1. Valkal Bhatt (47)
  2. Miguel-Angel Perales (27)
  3. Sean Devlin (27)
  4. Juliet Barker (25)
  5. Molly Maloy (25)
  6. Parastoo Dahi (23)

More People

Years
  1. 2022 (1)
  2. 2020 (7)
  3. 2019 (12)
  4. 2018 (7)
  5. 2017 (7)
  6. 2016 (5)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (30)
  2. Blood (11)
  3. Bone Marrow Transplantation (4)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Transplant Infectious Disease (1)
Publishers
  1. Elsevier Inc. (31)
  2. American Society of Hematology (11)
  3. Nature Publishing Group (4)
  4. Wiley Blackwell (1)

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
    Journal Article

    Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetic estimation of ATG exposure predicts immune reconstitution and survival in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; O'Reilly, R. J.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Research Letter

    Maples, K. T.; Maloy, M.; Devlin, S.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Incidence and risk factors for acute and chronic kidney injury after adult cord blood transplantation
    Journal Article

    Gutgarts, V.; Jaffer Sathick, I.; Zheng, J.; Politikos, I.; Devlin, S. M.; Maloy, M. A.; Giralt, S. A.; Scordo, M.; Bhatt, V.; Glezerman, I.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of and decreased inpatient hospital days for non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) patients with outpatient BEAM using daily etoposide and cytarabine and autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Cavalier, K.; Cazeau, N.; Bhatt, V.; McElrath, C.; LeStrange, N. J.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outpatient BEAM using daily etoposide and cytarabine with autologous hematopoietic stem cell transplantation for lymphoma is feasible and decreases inpatient length of stay
    Meeting Abstract

    Cazeau, N.; Cavalier, K.; Bhatt, V.; McElrath, C.; Lestrange, N.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine/ MMF for acute graft-vs-host disease (aGVHD) prophylaxis in adult double unit cord blood transplant (dCBT) recipients: Promising preliminary results of a phase II clinical trial
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save